Alexey Seregin

Alexey Seregin currently serves as the Senior Director of Platform at Ensoma since January 2025. Prior to this role, Alexey held the position of Vice President of Research & Development at Remedium Bio, where contributions included preclinical development of gene therapy programs and the creation of the Prometheus LNP-based DNA delivery technology. Previous experience includes significant roles at Takeda as Associate Director of Global Gene Therapy Research, overseeing multiple therapeutic programs and leading a research team, as well as similar positions at Solid Biosciences, Bioverativ, Biogen, and UTMB, focusing on viral vector technologies, gene delivery systems, and vaccine development. Alexey earned a Ph.D. in Molecular Virology from The University of Texas Medical Branch and has foundational degrees in Cytology and Genetics from Novosibirsk State University.